Immunotherapy in the adjuvant setting for high-risk melanoma

Clin Adv Hematol Oncol. 2018 Aug;16(8):546-548.
No abstract available

Publication types

  • Review

MeSH terms

  • Chemotherapy, Adjuvant / methods
  • Humans
  • Melanoma* / diagnosis
  • Melanoma* / genetics
  • Melanoma* / pathology
  • Melanoma* / therapy
  • Risk Factors